Plant Research Department, Nuclear Research Center, Atomic Energy Authority, Cairo, Egypt.
Biochemistry Lab, Chemistry Department, Faculty of Science, Cairo University, Giza, Egypt.
J Appl Microbiol. 2020 Mar;128(3):747-762. doi: 10.1111/jam.14510. Epub 2019 Nov 22.
Different endophytic fungi were isolated and screened for their digoxin-producing ability. Strain improvement and different culture conditions were studied for more effective production of digoxin.
Among the isolated fungi, an isolate produced digoxin in a concentration of 2·07 mg l . The digoxin-producing fungal isolate was identified as Epicoccum nigrum Link according to the morphological features and phylogenetic analyses. The potentiality of the fungal strain for production enhancement of digoxin was performed by gamma radiation mutagenesis. Gamma irradiation dose of 1000 Gy intensified the digoxin yield by five-fold. Using this dose, a stable mutant strain with improved digoxin productivity was isolated and the stability for digoxin production was followed up across four successive generations. In the effort to increase digoxin magnitude, selection of the proper cultivation medium, addition of some elicitors to the most proper medium and several physical fermentation conditions were tested. Fermentation process carried out in malt extract autolysate medium (pH 6·5) supplemented by methyl jasmonate and inoculated with 2 ml of 6-day-old culture and incubated at 25°C for 10 days stimulated the highest production of digoxin to attain 50·14 mg l . Moreover, cytotoxicity of digoxin separated from the fungal culture was tested against five different cancer cell lines. Based on the MTT assay, digoxin inhibited the proliferation of the five different cancer cell lines and the recorded 50% inhibitory concentration ranged from 10·76 to 35·14 μg ml .
This is the first report on the production and enhancement of digoxin using fungal fermentation as a new and alternate source with high productivity.
These findings offer new and alternate sources with excellent biotechnological potential for digoxin production by fungal fermentation. Moreover, digoxin proved to be a promising anticancer agent whose anticancer potential should be assessed in prospective cancer therapy.
分离和筛选具有产生洋地黄毒苷能力的不同内生真菌。研究了菌株改良和不同培养条件,以更有效地生产洋地黄毒苷。
在所分离的真菌中,有一种真菌在浓度为 2.07mg/L 时产生洋地黄毒苷。根据形态特征和系统发育分析,鉴定产洋地黄毒苷真菌分离物为链格孢属(Epicoccum nigrum Link)。通过伽马射线诱变对真菌菌株的产洋地黄毒苷能力进行了增强。辐照剂量为 1000Gy 时,洋地黄毒苷的产量提高了五倍。使用该剂量,分离出了一株具有提高洋地黄毒苷生产能力的稳定突变株,并对其连续四代的洋地黄毒苷生产稳定性进行了跟踪。为了提高洋地黄毒苷的产量,我们选择了合适的培养介质,在最适宜的培养基中添加了一些诱导剂,并测试了几种物理发酵条件。在麦芽提取物自溶物培养基(pH6.5)中添加茉莉酸甲酯,接种 2ml 培养 6 天的菌液,在 25°C 下培养 10 天的发酵过程刺激了洋地黄毒苷的最高产量,达到 50.14mg/L。此外,还测试了从真菌培养物中分离出的洋地黄毒苷对五种不同癌细胞系的细胞毒性。根据 MTT 测定,洋地黄毒苷抑制了五种不同癌细胞系的增殖,记录的 50%抑制浓度范围为 10.76 至 35.14μg/ml。
这是首次报道利用真菌发酵作为一种具有高产潜力的新的替代来源来生产和增强洋地黄毒苷。
这些发现为真菌发酵生产洋地黄毒苷提供了新的替代来源,具有极好的生物技术潜力。此外,洋地黄毒苷被证明是一种有前途的抗癌药物,其抗癌潜力应在未来的癌症治疗中进行评估。